Orekhov Alexander N, Nikiforov Nikita G, Zhuravlev Alexander D, Verkhova Svetlana S, Omelchenko Andrey V, Borodko Daria D, Sukhorukov Vasily N, Sinyov Vasily V, Sobenin Igor A
Institute of General Pathology and Pathophysiology, 8 Baltiiskaya Street, 125315, Moscow, Russia.
Petrovsky Russian National Center of Surgery, 2 Abrikosovsky Lane, 119991, Moscow, Russia.
Curr Med Chem. 2024 Sep 12. doi: 10.2174/0109298673303008240829075444.
Аims: This research aimed to study the features of gene regulation of the inflammatory response in cells carrying mitochondrial mutations associated with atherosclerosis.
Inflammation plays an important, if not decisive, role in the occurrence of atherosclerotic lesions and then accompanies it throughout its further development. Thus, atherogenesis is a chronic inflammatory process. Chronification of inflammation is a consequence of disruption of the normal inflammatory response at the cell level of the vascular wall.
In this study, we used cytoplasmic hybrids or cybrids carrying atherosclerosis-associated mitochondrial mutations to study gene regulation of inflammatory response. The main goal of the study was to identify the key genes responsible for the impaired inflammatory response revealed for some cybrids.
Inflammatory stimulation of cybrids was induced with bacterial lipopolysaccharide, and assessed through secretion of pro-inflammatory cytokines CCL2, IL8, IL6, IL1b. A transcriptome analysis was performed to identify the key genes (master regulators) in the normal (tolerant) and intolerant response of cybrid cells.
Normal inflammatory response after re-stimulation elicited a much smaller secretion of pro-inflammatory cytokines. In an intolerant response, the level of secretion upon re-stimulation was the same or even higher than after the first stimulation. Normal and intolerant responses differed significantly both in terms of the number of signaling pathways involved and qualitatively, since the signaling pathways for normal and intolerant responses are completely different. Master regulators controlling normal and intolerant inflammatory response were identified. For a normal response to the first inflammatory stimulation, no common master up-regulators and 3 master down-regulators were identified. The reverse situation was observed with the intolerant inflammatory response: 6 master up-regulators, and no master down regulators were identified. After the second inflammatory stimulation, no master regulator common to all studied cytokines was found. Thus, key genes involved in the development of intolerant inflammatory response have been identified. In addition, other key genes were identified that were initially associated with an intolerant inflammatory response and thus determine disorders of the inflammatory reaction leading to chronification of inflammation.
We identified disturbances in gene associated with the development of intolerant immune response that may be relevant to atherosclerosis. Key genes responsible for the chronification of inflammation were discovered.
本研究旨在探讨携带与动脉粥样硬化相关线粒体突变的细胞中炎症反应的基因调控特征。
炎症在动脉粥样硬化病变的发生中起着重要作用,甚至可以说是决定性作用,并且在其进一步发展过程中一直伴随。因此,动脉粥样硬化的发生是一个慢性炎症过程。炎症的慢性化是血管壁细胞水平正常炎症反应破坏的结果。
在本研究中,我们使用携带动脉粥样硬化相关线粒体突变的细胞质杂种细胞(cybrids)来研究炎症反应的基因调控。该研究的主要目的是确定导致一些cybrids细胞炎症反应受损的关键基因。
用细菌脂多糖诱导cybrids细胞的炎症刺激,并通过促炎细胞因子CCL2、IL8、IL6、IL1b的分泌进行评估。进行转录组分析以确定cybrids细胞正常(耐受)和不耐受反应中的关键基因(主调控因子)。
再次刺激后的正常炎症反应引发的促炎细胞因子分泌要少得多。在不耐受反应中,再次刺激后的分泌水平与第一次刺激后相同甚至更高。正常和不耐受反应在涉及的信号通路数量和质量上都有显著差异,因为正常和不耐受反应的信号通路完全不同。确定了控制正常和不耐受炎症反应的主调控因子。对于第一次炎症刺激的正常反应,未发现共同的主上调因子,发现了3个主下调因子。不耐受炎症反应则相反:发现了6个主上调因子,未发现主下调因子。第二次炎症刺激后,未发现所有研究细胞因子共有的主调控因子。因此,确定了参与不耐受炎症反应发展的关键基因。此外,还确定了其他最初与不耐受炎症反应相关的关键基因,从而确定了导致炎症慢性化的炎症反应紊乱。
我们确定了与不耐受免疫反应发展相关的基因紊乱,这可能与动脉粥样硬化有关。发现了导致炎症慢性化的关键基因。